Exam (elaborations)
Nifurtimox-Eflornithine Combination Therapy for SecondStage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Congo
- Course
- Institution
Human African trypanosomiasis (HAT), or sleeping sickness, remains a public health challenge in sub-Saharan Africa, with an estimated 50,000–70,000 new cases per year, of which ∼20,000 are detected and reported [1]. The disease is caused by the protozoan parasite Trypanosoma brucei gambiens...
[Show more]